Hepatitis B virus induced hepatocellular carcinoma

Cancer Letters

Volumn 286, Issue 1, 2009, Pages 52-59

  Chemin, I ^a,b,c   Zoulim, F ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ LYON 1   (France)

^c HÔTEL DIEU   (France)

Author keywords

Hepatitis B; Hepatocellularcinoma; Natural history; Occult infections

Indexed keywords

CYTOKINE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VIRUS X PROTEIN; VIRUS DNA; VIRUS PROTEIN;

CELL FUNCTION; CHRONIC INFLAMMATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SHORT SURVEY; VIRUS LOAD; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 70349253352     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.12.003     Document Type: Review

References (59)

1. I.J. Su, H.C. Wang, H.C. Wu, W.Y. Huang, Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection, J. Gastroenterol. Hepatol. (in press).
2. Soussan P., Garreau F., Zylberberg A., Ferray C., Brechot C., and Kremsdorf D. In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA. J. Clin. Invest. 105 (2000) 55-60
3. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans IARC Monograph, vol. 59, Hepatitis viruses, WHO press.
4. Koike K., Shimotouno K., Okada S., Okamoto H., Hayashi N., Ueda K., Kaneko S., Koike K., Yokosuka O., Chiba T., Marusawa H., Hino O., Utida T., Omata M., Juji T., Nojiri N., Takada K., Miyamura T., Osuga T., and Ito Y. Survey of hepatitis B virus co-infection in hepatitis C virus-infected patients suffering from chronic hepatitis and hepatocellular carcinoma in Japan. Jpn. J. Cancer Res. 90 (1999) 1270-1272
5. Pollicino T., Squadrito G., Cerenzia G., Cacciola I., Raffa G., Craxi A., Farinati F., Missale G., Smedile A., Tiribelli C., Villa E., and Raimondo G. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 126 (2004) 102-110
6. Sagnelli E., Coppola N., Scolastico C., Mogavero A.R., Stanzione M., Filippini P., Felaco F.M., and Piccinino F. Isolated anti-HBc in chronic hepatitis C predicts a poor response to interferon treatment. J. Med. Virol. 65 (2001) 681-687
7. Squadrito G., Pollicino T., Cacciola I., Caccamo G., Villari D., La Masa T., Restuccia T., Cucinotta E., Scisca C., Magazzu D., and Raimondo G. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. Cancer 106 (2006) 1326-1330
8. Mrani S., Chemin I., Menouar K., Guillaud O., Pradat P., Borghi G., et al. J. Med. Virol. 79 8 (2007) 1075-1081
9. Miura Y., Shibuya A., Adachi S., Takeuchi A., Tsuchihashi T., Nakazawa T., and Saigenji K. Occult hepatitis B virus infection as a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C in whom viral eradication fails. Hepatol. Res. 38 (2008) 546-556
10. Obika M., Shinji T., Fujioka S., Terada R., Ryuko H., Lwin A.A., Shiraha H., and Koide N. Hepatitis B virus DNA in liver tissue and risk for hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease. A prospective study. Intervirology 51 (2008) 59-68
11. Takeuchi M., Okamoto E., and Fujimoto J. Detection of HBV-DNA from hepatocellular carcinoma by polymerase chain reaction. Nippon Rinsho 53 (1995) 718-722
12. Kobayashi S., Saigoh K., Urashima T., Asano T., and Isono K. Detection of hepatitis B virus x transcripts in human hepatocellular carcinoma tissues. J. Surg. Res. 73 (1997) 97-100
13. Urashima T., Saigo K., Kobayashi S., Imaseki H., Matsubara H., Koide Y., Asano T., Kondo Y., Koike K., and Isono K. Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues. J. Hepatol. 26 (1997) 771-778
14. Shintani Y., Yotsuyanagi H., Moriya K., Fujie H., Tsutsumi T., Takayama T., Makuuchi M., Kimura S., and Koike K. The significance of hepatitis B virus DNA detected in hepatocellular carcinoma of patients with hepatitis C. Cancer 88 (2000) 2478-2486
15. Sheu J.C. Molecular mechanism of hepatocarcinogenesis. J. Gastroenterol. Hepatol. 12 (1997) S309-S313 Review
16. Grethe S., Heckel J.O., Rietschel W., and Hufert F.T. Molecular epidemiology of hepatitis B virus variants in nonhuman primates. J. Virol. 74 (2000) 5377-5381
17. Kidd-Ljunggren K., Miyakawa Y., and Kidd A.H. Genetic variability in hepatitis B viruses. J. Gen. Virol. 83 (2002) 1267-1280
18. Wang H.P., and Rogler C.E. Topoisomerase I-mediated integration of hepadnavirus DNA in vitro. J. Virol. 65 (1991) 2381-2392
19. Arauz-Ruiz P., Norder H., Robertson B.H., and Magnius L.O. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J. Gen. Virol. 83 (2002) 2059-2073
20. Kirk G.D., Bah E., and Montesano R. Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa. Carcinogenesis 27 (2006) 2070-2082
21. Livingston S.E., Simonetti J.P., McMahon B.J., Bulkow L.R., Hurlburt K.J., Homan C.E., Snowball M.M., Cagle H.H., Williams J.L., and Chulanov V.P. Hepatitis B virus genotypes in Alaska native people with hepatocellular carcinoma: preponderance of genotype F. J. Infect. Dis. 195 (2007) 5-11
22. Edmunds W.J., Medley G.F., Nokes D.J., Hall A.J., and Whittle H.C. The influence of age on the development of the hepatitis B carrier state. Proc. Biol. Sci. 253 (1993) 197-201
23. Rehermann B., and Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5 (2005) 215-229
24. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat. 11 (2004) 97-107 Review
25. Ganem D., and Prince A.M. Hepatitis B virus infection-natural history and clinical consequences. New Engl. J. Med. 11 (2004) 1118-1129
26. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 (2001) 539-545 Review
27. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., and Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39 (2007) 44-84 Review
28. Safadi R., and Friedman S.L. Hepatic fibrosis-role of hepatic stellate cell activation. Med. Gen. Med. 27 (2002)
29. Fattovich G., Stroffolini T., Zagni I., and Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127 (2004) S35-S50 Review
30. Villa E., Grottola A., Buttafoco P., Trande P., Merighi A., Fratti N., Seium Y., Cioni G., and Manenti F. Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis B. Dig. Dis. Sci. 40 (1995) 8-13
31. Berasain C., Betes M., Panizo A., Ruiz J., Herrero J.I., Civeira M.P., and Prieto J. Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut 47 (2000) 429-435
32. Chemin I., Zoulim F., Merle P., Arkhis A., Chevallier M., Kay A., Cova L., Chevallier P., Mandrand B., and Trepo C. High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J. Hepatol. 34 (2001) 447-454
33. Borzio M., Trerè D., Borzio F., Ferrari A.R., Bruno S., Roncalli M., Colloredo G., Leandro G., Oliveri F., and Derenzini M. Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis. Mol. Pathol. 51 (1998) 96-101
34. Kremsdorf D., Soussan P., Paterlini-Brechot P., and Brechot C. Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis. Oncogene 25 (2006) 3823-3833 Review
35. Bonilla Guerrero R., and Roberts L.R. The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma. J. Hepatol. 42 (2005) 760-777 Review
36. Tu H., Bonura C., Giannini C., Mouly H., Soussan P., Kew M., Paterlini-Bréchot P., Bréchot C., and Kremsdorf D. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res. 1 61 (2001) 7803-7810
37. Paterlini P., Poussin K., Kew M., Franco D., and Brechot C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 21 (1995) 313-321
38. Hildt E., Munz B., Saher G., Reifenberg K., and Hofschneider P.H. The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. EMBO J. 21 (2002) 525-535
39. Ron D., and Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell. Biol. 8 (2007) 519-529 Review
40. He B. Viruses, endoplasmic reticulam stress, and interferon responses. Cell Death Differ 13 (2006) 393-403 (Review)
41. Haynes C.M., Titus E.A., and Cooper A.A. Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death. Mol. Cell 15 (2004) 767-776
42. Travers K.J., Patil C.K., Wodicka L., Lockhart D.J., Weissman J.S., and Walter P. Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell 101 (2000) 249-258
43. Tu B.P., and Weissman J.S. Oxidative protein folding in eukaryotes: mechanisms and consequences. J. Cell Biol. 164 (2004) 341-346 Review
44. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., and Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39 (2007) 44-84
45. Deodhar K.P., Tapp E., and Scheuer P.J. Orcein staining of hepatitis B antigen in paraffin sections of liver biopsies. J. Clin. Pathol. 1 (1975) 66-70
46. Winckler K., Junge U., and Creutzfeldt W. Ground-glass hepatocytes in unselected liver biopsies. ultrastructure and relationship to hepatitis B surface antigen. Scand J. Gastroenterol. 11 (1976) 167-170
47. Amat D., Camilleri J.P., Feldmann G., Bloch F., Duboust A., and Bedrossian J. Hepatocyte localization of hepatitis B core and surface antigens in renal transplant recipients. An ultrastructural prospective study. Virchows Arch. A Pathol. Anat. Histol. 391 (1981) 153-163
48. Huang Z.M., and Yen T.S. Dysregulated surface gene expression from disrupted hepatitis B virus genomes. J. Virol. 67 (1993) 7032-7040
49. Xu Z., and Yen T.S. Intracellular retention of surface protein by a hepatitis B virus mutant that releases virion particles. J. Virol. 70 (1996) 133-140
50. Hsieh Y.H., Su I.J., Wang H.C., Chang W.W., Lei H.Y., Lai M.D., Chang W.T., and Huang W. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25 (2004) 2023-2032
51. Filippi P., Buras J., McLachlan A., and Chisari F.V. Overproduction of the hepatitis B virus large envelope polypeptide causes filament storage, ground glass hepatocyte formation, hepatocellular injury an nodular hyperplasia in transgenic mice. In: Zuckerman A.J. (Ed). Viral Hepatitis and Liver Disease (1988), Alan R Liss Inc. 632-640
52. Chemin I., Ohgaki H., Chisari F.V., and Wild C.P. Altered expression of hepatic carcinogen metabolizing enzymes with liver injury in HBV transgenic mouse lineages expressing various amounts of hepatitis B surface antigen. Liver 19 (1999) 81-87
53. Hagen T.M., Huang S., Curnutte J., Fowler P., Martinez V., Wehr C.M., Ames B.N., and Chisari F.V. Extensive oxidative DNA damage, in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 91 (1994) 12808-12812
54. Bouchard M.J., and Schneider R.J. The enigmatic X gene of hepatitis B virus. J. Virol. 78 (2004) 12725-12734
55. Summers J., and Mason W.S. Residual integrated viral DNA after hepadnavirus clearance by nucleoside analog therapy. Proc. Natl. Acad. Sci. USA 101 (2004) 638-640
56. Zhu Y., Cullen J.M., Aldrich C.E., Saputelli J., Miller D., Seeger C., Mason W.S., and Jilbert A.R. Adenovirus-based gene therapy during clevudine treatment of woodchucks chronically infected with woodchuck hepatitis virus. Virology 327 (2004) 26-40
57. Chen C.J., Yang H.I., Su J., Jen C.L., You S.L., and Lu S.N. REVEAL-HBV study group, risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295 (2006) 65-73
58. Yu M.W., Yeh S.H., Chen P.J., Liaw Y.F., Lin C.L., Liu C.J., Shih W.L., Kao J.H., Chen D.S., and Chen C.J. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J. Natl. Cancer Inst. 97 (2005) 265-272
59. Liaw Y.F. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy. Antivir. Ther. 11 (2006) 669-679